✦ LIBER ✦

European Association of Urology Guidelines for Systemic Therapy in Metastatic Renal Cell Carcinoma: What is Recommended and Why?

✍ Scribed by Jean-Jacques Patard

Book ID: 118440539
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 675 KB
Volume: 7
Category: Article
ISSN: 1569-9056
DOI: 10.1016/j.eursup.2007.12.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

MP6-06 POPULATION-LEVEL TRENDS IN THE AD

MP6-06 POPULATION-LEVEL TRENDS IN THE ADOPTION OF NOVEL TARGETED AGENTS FOR SYSTEMIC THERAPY AND IMPACT ON RATES OF CYTOREDUCTIVE NEPHRECTOMY FOR METASTATIC RENAL CELL CARCINOMA

✍ Psutka, Sarah; Kim, Simon; Gross, Cary; Van Houten, Holly; Thompson, R. Houston; 📂 Article 📅 2014 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 48 KB

Strategies for assessing and managing th

Strategies for assessing and managing the adverse events of sorafenib and other targeted therapies in the treatment of renal cell and hepatocellular carcinoma: Recommendations from a European nursing task group

✍ Kim Edmonds; Diana Hull; Andrea Spencer-Shaw; José Koldenhof; Maria Chrysou; Chr 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 520 KB

A pilot study of the effects of expressi

A pilot study of the effects of expressive writing on psychological and behavioral adjustment in patients enrolled in a Phase II trial of vaccine therapy for metastatic renal cell carcinoma.

✍ de Moor, Carl; Sterner, Janet; Hall, Martica; Warneke, Carla; Gilani, Zunera; Am 📂 Article 📅 2002 🏛 American Psychological Association 🌐 English ⚖ 248 KB

Efficacy of everolimus in second- and th

Efficacy of everolimus in second- and third-line therapy for metastatic renal cell carcinoma: A registry-based analysis11T.B. and B.M. received honoraria for advisory boards and lectures from Novartis and Pfizer. K.K. received honoraria for advisory boards and lectures from Novartis. Other authors have declared no conflict of interest. The RENIS registry is funded in part by pharmaceutical companies producing targeted agents for renal cancer (Pfizer, Bayer, GSK, Roche, and Novartis).

✍ Buchler, Tomas; Bortlicek, Zbynek; Poprach, Alexandr; Kubackova, Katerina; Kiss, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 327 KB